These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24122656)

  • 21. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
    Liu J; Lin G; Huang J; Jiang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma.
    Chodynicki S; Chyczewski L; Olszewska E
    Med Sci Monit; 2002 May; 8(5):BR184-6. PubMed ID: 12011767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of cholesteatomas under a scanning electron microscope - a risk factor for bone resorption.
    Wiatr A; Job K; Wiatr M
    Acta Otorhinolaryngol Ital; 2021 Aug; 41(4):371-376. PubMed ID: 34533541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
    Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
    Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V; Bujia J; Negri B; Kastenbauer E
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some markers of proliferative activity in cholesteatoma epithelium in adults.
    Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
    Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
    Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
    Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
    Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.
    Bujía J; Kim C; Ostos P; Kastenbauer E; Hültner L
    Eur Arch Otorhinolaryngol; 1996; 253(3):152-7. PubMed ID: 8652157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiology of cholesteatoma].
    Gersdorff MC; Debaty ME; Tomasi JP
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):115-9. PubMed ID: 17007181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone SPECT in cholesteatoma assessment.
    Añó T; Ciurana R; Figuerola E; Martínez de Vírgala C; Reverter C; Risco J
    Acta Otorhinolaryngol Belg; 1997; 51(1):35-8. PubMed ID: 9105481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis in the pathogenesis of cholesteatoma in adults.
    Olszewska E; Chodynicki S; Chyczewski L
    Eur Arch Otorhinolaryngol; 2006 May; 263(5):409-13. PubMed ID: 16378223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.